BOBULSKY SUSAN (SVP, Diagnostics, clonoSEQ) sold 0.3% of their position (1.30K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $31.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/3/2026ACC: 0001820885-26-000018
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
-1.30K
Net shares
Net seller
$31.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.30K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.30K
Price / share
$24.00
Trade value
$31.18K
% of position
0.3%
7/30/2026
401.29K→399.99K
Total
Net shares
−1.30K
Net value
-$31.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/30/2026 | S · Sale | −1.30K | $24.00 | $31.18K | 0.3% | 401.29K | 399.99K |
| Total | −1.30K | -$31.18K | ||||||
Derivative Transactions0
No derivative transactions reported